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Abstract
Introduction: Intensive care medicine can contribute to population health in low-income 
countries by reducing premature mortality related to surgery, trauma, obstetrical and other medical 
emergencies. Quality improvement is guided by risk stratification models, which are developed 
primarily within high-income settings. Models validated for use in low-income countries are 
needed.
Methods: This prospective cohort study consisted of 261 patients admitted to the intensive care 
unit (ICU) of K***** Central Hospital in Malawi, from September 2016 to March 2018. The 
primary outcome was in-hospital mortality. We performed univariable analyses on putative 
predictors and included those with a significance of 0.15 in the Malawi Intensive care Mortality 
risk Evaluation model (MIME). Model discrimination was evaluated using the area under the 
curve.
Results: Males made up 37.9% of the study sample and the mean age was 34.4 years. A majority 
(73.9%) were admitted to the ICU after a recent surgical procedure, and 59% came directly from 
the operating theater. In-hospital mortality was 60.5%. The MIME based on age, sex, admitting 
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service, systolic pressure, altered mental status, and fever during the ICU course had a fairly good 
discrimination, with an AUC of 0.70 (95% CI 0.63–0.76).
Conclusions: The MIME has modest ability to predict in-hospital mortality in a Malawian ICU. 
Multicenter research is needed to validate the MIME and assess its clinical utility.
Keywords
global surgery; low-income; critical care; risk model
Introduction
The delivery of high-quality intensive care medicine may decrease mortality from trauma, 
infectious disease, obstetric conditions, and surgical complications[1–3]. Morbidity and 
mortality from these conditions are disproportionately high in low- and middle-income 
countries (LMICs), where intensive care unit (ICU) expertise and bed availability is 
lowest[4]. In order to effectively assess the provision and quality of intensive care medicine 
in LMICs, appropriate risk stratification models are needed. These models may allow for 
better interpretation of the severity of illness and corresponding mortality rates in regions 
where critical care services are still developing, facilitate risk-adjusted comparisons of 
critical care populations in disparate settings, and inform resource allocation in LMICs[5].
The majority of ICU risk stratification models developed to date have been based upon 
cohorts in high-income settings, which limits their generalizability to LMIC populations, 
where population demographics, environmental exposures, and critical care capabilities and 
practices are different [6–12]. Many ICU risk models are also not feasible for LMICs 
because they require too many assessments and/or laboratory measurements. The objective 
of this study was to utilize routinely collected data to develop an ICU mortality prediction 
model for use in Malawi and other LMICs.
Methods
This was prospective, observational cohort study of all patients admitted to the ICU of 
K***** Central Hospital (KCH) in Lilongwe, Malawi. Data collection occurred from 
September 2016 to March 2018 based on the funding period. Based on our previous work at 
this and nearby study sites[13, 14], we anticipated that this timeline would be adequate to 
achieve a sample size of approximately 250 patients, consistent with other similar studies in 
the field [15, 16]. The study protocol was developed a priori and approved by the National 
Health Sciences Research Council of Malawi and the Institutional Review Boards of both 
American universities with which the study was affiliated, and the requirement for written 
informed consent was waived by all. The study was registered at researchregistry.com under 
protocol 4330. Malawi is a country in southern Africa with a population of 18 million 
people, a life expectancy of 63.8 years, and a Human Development Index rank of 170 out of 
187 countries[17]. It is the sixth poorest country in sub-Saharan Africa[18]. KCH is a central 
referral hospital in the central region of Malawi with a catchment area of approximately 5 
million.
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The data were collected prospectively by clerks specifically trained in ICU data abstraction. 
The clerks started data collection for each patient at the time of ICU admission by medical 
chart review and followed the patients to hospital discharge or death. Data collected included 
date of hospital admission, location before ICU admission (e.g. Emergency Room, 
Operating Theater, Ward), admitting service (e.g. Surgery, Obstetrics and Gynecology, 
Medicine, Pediatrics), vital signs and laboratory measurements at the time of ICU admission 
treatments utilized in ICU (e.g. mechanical ventilation, blood transfusion), location to which 
patients were discharged, and the hospital discharge date.
Vital signs collected included an assessment of mental status using the AVPU scale (Alert, 
Verbally-responsive, Painful-stimulus responsive, and Unresponsive), which was simpler 
and more acceptable to local clinicians than the Glasgow Coma Scale Because AVPU was 
frequently confounded by postoperative residual anesthesia, during data analysis we 
simplified it into an assessment of altered mental status (any value other than Alert). In 
addition to standard vital sign measurements, we also assessed for the clinical suspicion of 
infection at ICU admission and for the presence of fever (>38.4°C) at any time during the 
ICU course. Questions about data points were addressed by an author who is full-time ICU 
clinical officer at KCH (CK). All records were initially kept on paper and then maintained in 
a de-identified computer database.
Exclusion criteria for patients included age ≤15 years old, readmission to ICU (e.g. only the 
index admission was included), and ICU admission for a reported head injury; supplemental 
analyses included patients (1) with missing HIV serostatus managed via list-wise deletion, 
forced into the model, or imputed as negative and positive as per other studies in the 
literature[19], and (2) with a reported head injury to assess the validity of the predictive 
model in the larger cohort. The primary outcome was in-hospital mortality.
We first described the cohort, looking for differences between survivors and non-survivors. 
We performed a univariable analysis on all independent predictors for in-hospital mortality 
and included those that reached a significance level of ≤0.15 and had a low proportion of 
missing values (<10%) in the final model, the Malawi Intensive care Mortality risk 
Evaluation (MIME). A simplified Malawi Intensive care Mortality Evaluation (simple 
MIME) was explored and developed using a backward elimination procedure with a 
criterion of p < 0.10 from the full model, to provide an alternative that would be especially 
simple to implement in low-resourced environments. Model discrimination was evaluated 
using the area under the receiver operating characteristic curve (AUROC, or c-statistic) with 
95% confidence intervals (CI). The area under the curve (AUC) summarizes how well a 
model is able to accurately delineate hospital survival after ICU admission. Model fit was 
assessed using Hosmer-Lemeshow Goodness-of-Fit, Akaike information criterion (AIC), 
and R-squared. Internal validation of model accuracy was performed using 10-fold cross 
validation. Statistical analyses were conducted using SAS Version 9.4 (SAS Institute, Inc., 
Cary, NC). The results are reported in line with the STROCSS criteria.[20]
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Between September 2016 and March 2018, 431 patients were admitted to the study ICU. 
After excluding readmissions (n=7), patients ≤15 years of age (n=84), and those with a head 
injury (n=88), 276 patients were eligible for analysis. Exclusion criteria were not mutually 
exclusive. Fifteen patients were missing outcome data and were also excluded, for a total 
cohort of 261 patients. Males accounted for 37.9% of the cohort, and the mean age was 34.4 
±15.1 years (range 16–84 years). A majority of the patients (73.9%) were admitted to the 
ICU after a recent surgical procedure, and 58.6% came directly from the operating theater 
while 24.5% were admitted from one of the hospital’s four High-Dependency Units. Overall 
in-hospital mortality in the cohort was 60.5%. (Table 1)
The full Malawi Intensive care Mortality risk Evaluation (MIME) model includes the 
following variables: age, sex, ICU admitting service, systolic blood pressure at ICU 
admission, altered mental status at ICU admission, and the presence of a fever during the 
ICU course. All variables included in the final model had <10% in missing responses. 
(Appendix, Table A1) The model demonstrated good discrimination, with an AUC of 0.70 
(95% CI 0.63–0.76), an average sensitivity of 83.9% (±10.6) in the 10-fold cross-validation. 
(Tables 2 and 3, Figures 1 and 2)
We examined an alternative model, the simplified Malawi Intensive care Mortality 
Evaluation (sMIME), which included ICU admitting service, altered mental status at ICU 
admission, and the presence of fever during the ICU course. (Table 2) This model included 
fewer variables and demonstrated similar discrimination as the full model with an AUC of 
0.68 (95% CI 0.62–0.75). When internally validated, the sMIME model also performed with 
the same level of sensitivity as the full model. (Tables 2 and 3, Figure 3)
Sensitivity analyses of the multivariable models were explored with the missing HIV 
serostatus cases managed via list wise deletion, when forced in the model, or imputed as 
negative and as positive. With the missing HIV serostatus cases imputed as negative or as 
positive, the model also included the HIV status. The model AUC for the MIME in both 
these analyses was 0.71 (95% CI 0.64–0.77). By excluding missing HIV status cases but 
forcing HIV status into the predictive model, the model AUC was 0.72 (95% CI 0.65–0.79). 
(Appendix Tables A2–3)
Supplemental analyses that included patients with a severe head injury at ICU admission 
yielded similar results. In these analyses, which included 325 patients, the MIME included 
the same variables as the primary analysis and demonstrated modest discrimination with an 
AUC of 0.69 (95% CI 0.63–0.75) and an average of 81% (±9.4) sensitivity in the 10-fold 
internal validation assessment. With the inclusion of patients with head injuries, the 
simplified MIME incorporated systolic blood pressure at ICU admission and demonstrated a 
model AUC of 0.68 (05% CI 0.62–0.74). (Supplement Tables S1–6, Supplement Figures 
S1–S3)
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The Malawi Intensive care Mortality Evaluation model (MIME) demonstrated modest ability 
to predict in-hospital mortality in a population of Malawian ICU patients. Its component 
variables were easily collected during the clinical care of an ICU patient in a low-resource 
setting without the need for invasive monitors or laboratory measurements. This score may 
be considered as a useful retrospective tool to evaluate expected versus observed in-hospital 
mortality for patients with critical illness in low-income settings but should be externally 
validated within other sub-Saharan African populations before broad application in future 
studies. We anticipate its utility to be derived in comparative retrospective studies of critical 
care services worldwide.
The World Health Organization recommends that any facility providing surgery should have 
critical care services[21]. This is still a challenge in many LMICs[4], including Malawi 
where ICU bed availability is only 1 bed per 1 million population[22]. The overall in-
hospital mortality for ICU patients at this study site is high (60.5%). Although this is a 
relatively new area of research, the available prospective literature confirms high in-hospital 
mortality for ICU patients throughout the Eastern and Central African region, ranging from 
46.6% to 50%[15, 16, 23]. An assessment of patients’ critical illness severity is imperative to 
contextualize this mortality rate. The MIME serves this purpose, and has discrimination 
within range of other newly developed models for sub-Saharan Africa[15, 16]. The 
development of all of these models suffers from small sample sizes, but it is nonetheless a 
first step towards framing critical care services in this region.
The past decade of research in global public health has demonstrated the importance of 
addressing non-communicable diseases [24, 25] and surgery[26] to improve population 
health in LMICs. Public health interventions are most successful when they are multimodal, 
incorporating both disease-specific interventions (e.g. medications) and systems-level 
improvements (e.g. protocols and infrastructural improvements). For example, the rollout of 
medications for human immunodeficiency virus (HIV) in Rwanda between 1996 and 2013 
was supplemented by changes in the healthcare system (namely, decentralization of testing 
centers and changes in user fee structures), which led to improved overall success in slowing 
the HIV epidemic[27]. Improving access to safe surgical care should take these lessons into 
account; quality critical care services are essential to this mission. Scoring models feasible 
for use in low-resourced settings will contribute to better understanding of critically ill 
patients in this region and form one piece of this effort to improve access for safe surgery.
Critical care services must be tailored to the local disease epidemiology, practice patterns, 
and resources. Though there is scarce ICU research within LMICs to date, available data 
demonstrate that ICU patients in LMICs are younger and more likely to be admitted to ICU 
following trauma or surgery compared to cohorts in high-income settings[13, 14, 28–31]. 
Our findings are consistent with these observations. However, the effects of endemic tropical 
diseases (e.g. HIV, malaria) on critical illness are not yet well-defined. These conditions, 
including malaria, typhoid [32], schistosomiasis[33], and HIV[34] are common in 
hospitalized patients in sub-Saharan Africa. These infections affect endothelial and immune 
function[35, 36], which may have implications for the development, and severity of sepsis or 
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other multiorgan dysfunction states. This may be a missing link in developing risk 
stratification models with better discrimination. We attempted to address this question in 
part by including sensitivity analyses on the HIV serostatus of our patients, but future 
research may aim to evaluate a broader spectrum of endemic tropical diseases.
There are several limitations to this study. First, the challenges of conducting prospective 
clinical research in a low-resource setting must be emphasized and underlies some of the 
missing values in our dataset. Our supplemental analyses were designed to remain consistent 
with other reports in the literature, but also to address this limitation. Second, we did not 
include laboratory or clinical values frequently measured in high-income settings. While we 
recognize that certain laboratories (e.g. white blood cell count, lactate) and clinical 
assessments such as the Systemic Inflammatory Response Syndrome (SIRS) have been used 
for critical illness risk stratification [37–40], these are not regularly available in the study 
ICU. Therefore, this was done as part of our commitment to working within the confines of 
the Malawi healthcare system, and to increase the generalizability of this work to other 
LMICs. Finally, since we developed the MIME and simple-MIME model from this dataset, 
the model AUC needs to be externally validated.
Conclusions
Risk stratification models are necessary to inform critical care systems worldwide. Models 
created within and for LMICs are critical to improving the quality of global surgery and 
treatments for non-communicable diseases. The MIME model provides moderate 
discrimination for ICU in-hospital mortality in Malawi. It may be considered as a measure 
of in-hospital mortality risk for patients with critical illness in low-resource settings and may 
facilitate comparisons with high-income regions. Further application will rely on external 
validation.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Appendix
Table A1.
Proportion of Missing Responses in Potential Variables for Malawi Intensive care Mortality 
risk Evaluation (MIME) Model
  
Potential Variables in New Model No. of Missing (%)
Age 0 (0)
Male Sex 0 (0)
ICU Admitting Service 0 (0)
Post-Operative Status 1 (0.4)
Fever (>38.4C) During ICU Course 2 (0.8)
Measured at ICU Admission:
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Tachypnea (Heart Rate ≥100 bpm) 4 (1.5)
Systolic Blood Pressure 5 (1.9)
Altered Mental Status 6 (2.3)
Presence of Breathing Tube 0 (0)
Suspected Infection 1 (0.4)
Plasma Hemoglobin 30 (11.5)
HIV Status 48 (18.4)
Malaria Status 75 (28.7)
Table A2.
Summary of hospital mortality and univariable analysis of independent predictors of hospital 
mortality, with HIV status excluded when missing versus imputation as positive or negative 
when missing
Variables






















Crude OR (95% CI)
HIV Status – 
exclude 
missing
213 32 (15) 86 8 (9.3) 127 24 (18.9) 2.28 (0.97, 5.33) 0.06
HIV Status – 
missing as 
negative
261 32 (12.3) 103 8 (7.8) 158 24 (15.2) 2.13 (0.92, 4.94) 0.08
HIV Status – 
missing as 
positive
261 80 (30.7) 103 25 (24.3) 158 55 (34.8) 1.67 (0.96, 2.91) 0.07
CI: confidence interval; HIV: human immunodeficiency virus; IQR: interquartile range; No.: number; SD: standard 
deviation; OR: odds ratio
Table A3.
Sensitivity Analysis Tables for HIV in Primary Analysis of Model Performance (excluding 
head injury patients)
MIME Model sMIME Model
N Adj. OR (95% CI) Covariates in model
Model AUC 
(95% CI) N
Adj. OR (95% 







252 1.72 (0.94, 3.18)





0.71 (0.64, 0.77) 254 1.94 (1.07, 3.54)








252 2.19 (0.89, 5.38)





0.71 (0.64, 0.77) 254 2.21 (0.91, 5.35)
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208 2.39 (0.96, 5.96)





0.72 (0.65, 0.79) 209 2.67 (1.09, 6.52)
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Area Under the Receiver Operating Curve (AUC) with 95% Confidence Intervals (CI) for 
Malawi Intensive care Mortality risk Evaluation (MIME) Model and simplified MIME 
(sMIME), and AUC for 10-fold cross validation (CV) results
Prin et al. Page 11














10-fold cross-validated Receiver Operating Curve for Malawi Intensive care Mortality risk 
Evaluation (MIME) Model
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10-fold cross-validated Receiver Operating Curve for simplified Malawi Intensive care 
Mortality risk Evaluation (sMIME) Model
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